Design and Manufacture of Pharmaceutical Tablets. (Record no. 41713)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 06195nam a22004813i 4500 |
| 001 - CONTROL NUMBER | |
| control field | EBC1811527 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | MiAaPQ |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240729123115.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d | |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cnu|||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 240724s2014 xx o ||||0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780128021873 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9780128021828 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (MiAaPQ)EBC1811527 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (Au-PeEL)EBL1811527 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (CaPaEBR)ebr10950298 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (CaONFJC)MIL649667 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)899273378 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | MiAaPQ |
| Language of cataloging | eng |
| Description conventions | rda |
| -- | pn |
| Transcribing agency | MiAaPQ |
| Modifying agency | MiAaPQ |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RS200 -- .E956 2015eb |
| 082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615.1 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Eyjolfsson, Reynir. |
| 245 10 - TITLE STATEMENT | |
| Title | Design and Manufacture of Pharmaceutical Tablets. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 1st ed. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | San Diego : |
| Name of producer, publisher, distributor, manufacturer | Elsevier Science & Technology, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2014. |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | ©2015. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (68 pages) |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Cover -- Title Page -- Copyright Page -- Dedication -- Contents -- Preface -- Abbreviations -- Chapter One - Introduction -- 1.1 - General considerations -- 1.2 - Particle sizes -- 1.3 - Excipients -- 1.3.1 - Ac-Di-Sol SD-711 -- 1.3.2 - Aerosil 200 -- 1.3.3 - Avicel PH-102 -- 1.3.4 - Compactrol -- 1.3.5 - Corn starch -- 1.3.6 - Di-Tab -- 1.3.7 - Eudragit RS PO -- 1.3.8 - Magnesium stearate 5712 -- 1.3.9 - Mannitol 60 -- 1.3.10 - Methocel K4M Premium -- 1.3.11 - Methocel K100M Premium -- 1.3.12 - Methocel K100LV Premium -- 1.3.13 - Pharmatose 150M -- 1.3.14 - Polyplasdone XL-10 -- 1.3.15 - Povidone -- 1.3.16 - Primojel -- 1.3.17 - Pruv -- 1.3.18 - Sodium bicarbonate -- 1.3.19 - Starch 1500 -- 1.3.20 - Stearic acid 2236 -- 1.3.21 - Sterotex K -- 1.3.22 - Tablettose 80 -- 1.3.23 - Talc -- 1.4 - Equipment -- 1.5 - Mixing of pharmaceutical powders -- 1.6 - Design of experiments -- 1.6.1 - Introduction to statistical design of experiments - the two-level factorial -- 1.6.1.1 - Introduction -- 1.6.1.2 - Designed experiments -- 1.6.1.3 - Basic considerations -- 1.6.1.4 - Two-level factorials -- 1.6.1.5 - Two-level fractional factorials -- 1.6.2 - Response surface methodology (RSM) -- 1.6.2.1 - Introduction -- 1.6.2.2 - RSM and a sieving process variable study -- 1.6.2.3 - RSM investigation of the properties of a three-component tablet formulation -- References -- Chapter two - Conventional-Release (CR) Tablets -- 2.1 - Low-dose tablet by direct compression (DC) -- 2.1.1 - Properties of active pharmaceutical ingredient (API) -- 2.1.2 - Design -- 2.1.3 - Manufacturing method -- 2.1.4 - Remarks -- 2.2 - High-dose tablet by direct compression -- 2.2.1 - Properties of active pharmaceutical ingredient -- 2.2.2 - Design -- 2.2.3 - Manufacturing method -- 2.2.4 - Remarks -- 2.3 - Low-solubility API, low-dose tablet by wet granulation (WG). |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 2.3.1 - Properties of active pharmaceutical ingredient -- 2.3.2 - Design -- 2.3.3 - Manufacturing method -- 2.3.4 - Remarks -- 2.4 - Soluble API, low-dose tablet by wet granulation -- 2.4.1 - Properties of active pharmaceutical ingredient -- 2.4.2 - Design -- 2.4.3 - Manufacturing method -- 2.4.4 - Remarks -- 2.5 - Low-solubility API, high-dose tablet by wet granulation -- 2.5.1 - Properties of active pharmaceutical ingredient -- 2.5.2 - Design -- 2.5.3 - Manufacturing method -- 2.5.4 - Remarks -- 2.6 - Soluble API, high-dose tablet by wet granulation -- 2.6.1 - Properties of active pharmaceutical ingredient -- 2.6.2 - Design -- 2.6.3 - Manufacturing method -- 2.6.4 - Remarks -- References -- Chapter three - Slow-Release (SR) Tablets -- 3.1 - Slow-release tablet using a lipophilic release control agent -- 3.1.1 - Properties of active pharmaceutical ingredient (API) -- 3.1.2 - Design -- 3.1.3 - Manufacturing method -- 3.1.4 - Remarks -- 3.2 - Slow-release tablet using Eudragit and Methocel as release control agents -- 3.2.1 - Properties of active pharmaceutical ingredient -- 3.2.2 - Design -- 3.2.3 - Manufacturing method -- 3.2.4 - Remarks -- 3.3 - Slow-release tablet using a mixture of Methocels as release control agent -- 3.3.1 - Properties of active pharmaceutical ingredient -- 3.3.2 - Design -- 3.3.3 - Manufacturing method -- 3.3.4 - Remarks -- Reference -- Index. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Design and Manufacture of Pharmaceutical Tablets offers real world solutions and outcomes of formulation and processing challenges of pharmaceutical tablets. This book includes numerous practical examples related to actual formulations that have been validated and marketed and covers important data in the areas of stability, dissolution, bioavailibity and processing. It provides important background and theoretical information on design and manufacturing and includes a full section dedicated to design experimental methodology and statistics. In addition, this book offers a a general discussion of excipients used in proper tablet design along with practical examples related to excipients. Drug development scientists in industry and academia, as well as students in the pharmaceutical sciences will greatly benefit from the practical knowledge and case examples provided throughout this book. Incorporates important mathematical models and computational applications Includes unique content on central composite design and augmented simplex lattice Provides background on important design principles with emphasis on quality-based design (QBD) of pharmaceutical dosage forms. |
| 588 ## - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Description based on publisher supplied metadata and other sources. |
| 590 ## - LOCAL NOTE (RLIN) | |
| Local note | Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drugs -- Dosage forms. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pharmaceutical industry. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Tablets (Medicine). |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Print version: |
| Main entry heading | Eyjolfsson, Reynir |
| Title | Design and Manufacture of Pharmaceutical Tablets |
| Place, publisher, and date of publication | San Diego : Elsevier Science & Technology,c2014 |
| International Standard Book Number | 9780128021828 |
| 797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN) | |
| Corporate name or jurisdiction name as entry element | ProQuest (Firm) |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=1811527">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=1811527</a> |
| Public note | Click to View |
No items available.